Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells.
Saved in:
| Title: | Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells. |
|---|---|
| Authors: | Sato-Nagaoka, Yuri1 (AUTHOR), Suzuki, Susumu1,2,3 (AUTHOR), Suzuki, Souma2 (AUTHOR), Takahashi, Shinichiro1,2,3 (AUTHOR) shintakahashi@tohoku-mpu.ac.jp |
| Source: | PLoS ONE. 12/31/2024, Vol. 19 Issue 12, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
